A drug with the SMILES Cc1ccc(-n2c(C)cc(/C([O-])=C(/C(=S)Nc3ccc(F)c(Cl)c3)[n+]3ccccc3)c2C)cc1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 16.360\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1ccc(-n2c(C)cc(/C([O-])=C(/C(=S)Nc3ccc(F)c(Cl)c3)[n+]3ccccc3)c2C)cc1
Cc1ccc(-n2c(C)cc(/C([O-])=C(/C(=S)Nc3ccc(F)c(Cl)c3)[n+]3ccccc3)c2C)cc1
(E)-3-(3-chloro-4-fluoroanilino)-1-[2,5-dimethyl-1-(4-methylphenyl)pyrrol-3-yl]-2-pyridin-1-ium-1-yl-3-sulfanylideneprop-1-en-1-olate